Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial.

Luntamo M, Kulmala T, Cheung YB, Maleta K, Ashorn P.

Trop Med Int Health. 2013 Apr;18(4):386-97. doi: 10.1111/tmi.12074. Epub 2013 Feb 22.

2.

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.

PMID:
16826475
3.

The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial.

Luntamo M, Rantala AM, Meshnick SR, Cheung YB, Kulmala T, Maleta K, Ashorn P.

PLoS One. 2012;7(7):e41123. doi: 10.1371/journal.pone.0041123. Epub 2012 Jul 19.

4.

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi.

Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL.

Ann Trop Med Parasitol. 1998 Mar;92(2):141-50.

PMID:
9625909
5.

Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.

Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, Brasseur P.

Malar J. 2008 Nov 7;7:234. doi: 10.1186/1475-2875-7-234.

6.

Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial.

Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K, Ashorn P.

Am J Trop Med Hyg. 2010 Dec;83(6):1212-20. doi: 10.4269/ajtmh.2010.10-0264.

7.

Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial.

Unger HW, Ome-Kaius M, Wangnapi RA, Umbers AJ, Hanieh S, Suen CS, Robinson LJ, Rosanas-Urgell A, Wapling J, Lufele E, Kongs C, Samol P, Sui D, Singirok D, Bardaji A, Schofield L, Menendez C, Betuela I, Siba P, Mueller I, Rogerson SJ.

BMC Med. 2015 Jan 16;13:9. doi: 10.1186/s12916-014-0258-3.

8.

Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.

Wolfe EB, Parise ME, Haddix AC, Nahlen BL, Ayisi JG, Misore A, Steketee RW.

Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):178-86.

PMID:
11442215
9.

Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99.

Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango C, Molyneux ME.

Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):549-53.

PMID:
11132387
10.

Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.

Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW.

Lancet Infect Dis. 2012 Dec;12(12):942-9. doi: 10.1016/S1473-3099(12)70222-0. Epub 2012 Sep 18. Review.

PMID:
22995852
11.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

PMID:
18008241
12.

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.

Hommerich L, von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA, Eggelte TA, Bienzle U, Mockenhaupt FP.

Malar J. 2007 Nov 8;6:144.

13.

Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.

Challis K, Osman NB, Cotiro M, Nordahl G, Dgedge M, Bergström S.

Trop Med Int Health. 2004 Oct;9(10):1066-73.

14.

Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).

Likwela JL, D'Alessandro U, Lokwa BL, Meuris S, Dramaix MW.

Trop Med Int Health. 2012 Mar;17(3):322-9. doi: 10.1111/j.1365-3156.2011.02935.x. Epub 2011 Dec 30.

15.

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW.

Am J Trop Med Hyg. 1998 Nov;59(5):813-22.

PMID:
9840604
17.
18.

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.

J Infect Dis. 2007 Dec 1;196(11):1577-84. Epub 2007 Oct 25.

PMID:
18008240
19.

Antimalarials during pregnancy: a cost-effectiveness analysis.

Schultz LJ, Steketee RW, Chitsulo L, Wirima JJ.

Bull World Health Organ. 1995;73(2):207-14.

20.

A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.

Tukur IU, Thacher TD, Sagay AS, Madaki JK.

Am J Trop Med Hyg. 2007 Jun;76(6):1019-23.

PMID:
17556604

Supplemental Content

Support Center